| Name | Title | Contact Details |
|---|---|---|
Jerome Bonhomme |
Chief Technology Officer | Profile |
Voyager Therapeutics is a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS). Voyager is committed to advancing the field of AAV (adeno-associated virus) gene therapy through innovation and investment in vector optimization and engineering, dosing techniques, as well as process development and production. The company’s initial pipeline is focused on CNS diseases in dire need of effective new therapies, including Parkinson’s disease, a monogenic form of amyotrophic lateral sclerosis (ALS), and Friedreich’s ataxia. Founded by scientific and clinical leaders in the fields of AAV gene therapy, expressed RNA interference and neuroscience, Voyager Therapeutics was launched in 2014 with funding from leading life sciences investor Third Rock Ventures and is headquartered in Cambridge, Mass.
VIDA MEDICAL GROUP, LA is a Lawndale, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Vertiflex is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in San Clemente, CA. To find more information about Vertiflex, please visit www.vertiflex.net
Burke County Hospital Auxiliary, Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Waynesboro, GA. To find more information about Burke County Hospital Auxiliary, Inc, please visit www.burkemedical.net
At Gynesonics our mission is to design and develop new and advanced technologies for improving women`s health. We are focused on providing an incision-free option to women and the physicians who care for them, in treating symptomatic uterine fibroids. We are initiating a pivotal IDE trial in the United States to verify the safety and efficacy of the Sonata system, in preserving the uterus while treating those fibroids associated with abnormal uterine bleeding that are difficult to treat with existing technology and surgical techniques. We are committed to providing women with a safe and effective incision-free alternative to the invasive surgical techniques of hysterectomy or myomectomy for their severe menstrual symptoms associated with fibroids.